SELESTIAL: Trial of Insulin to Control Blood Sugar After Acute Stroke Using Magnetic Resonance Imaging (MRI) End-Points
PHASE2CompletedINTERVENTIONAL
Enrollment
45
Participants
Timeline
Start Date
May 31, 2004
Conditions
Acute StrokeHyperglycemia
Interventions
DRUG
Insulin
Trial Locations (1)
G51 4TF
Institute of Neurological Sciences, Glasgow
All Listed Sponsors
collaborator
South Glasgow University Hospitals NHS Trust
OTHER
collaborator
The Stroke Association, United Kingdom
OTHER
lead
University of Glasgow
OTHER
NCT00124826 - SELESTIAL: Trial of Insulin to Control Blood Sugar After Acute Stroke Using Magnetic Resonance Imaging (MRI) End-Points | Biotech Hunter | Biotech Hunter